Analgesic tablet consumption at baseline and six follow-up cycles
Group B | ||||||
---|---|---|---|---|---|---|
Group A (Control for vitamin K) | (Control for point location) | Group C(Standard) | ||||
Mean | (SD) | Mean | (SD) | Mean | (SD) | |
Baseline | 0.93 | 0.82 | 0.82 | 0.56 | 0.89 | 0.77 |
Cycle 2 | 0.22 | 0.42 | 0.41 | 0.57 | 0.27 | 0.45 |
Cycle 3 | 0.11 | 0.32 | 0.33 | 0.48 | 0.35 | 0.49 |
Cycle 4 | 0.22 | 0.42 | 0.41 | 0.5 | 0.27 | 0.45 |
Cycle 5 | 0.22 | 0.42 | 0.48 | 0.5 | 0.35 | 0.49 |
Cycle 6 | 0.33 | 0.48 | 0.48 | 0.58 | 0.23 | 0.43 |
Cycle 7 | 0.22 | 0.42 | 0.33 | 0.48 | 0.23 | 0.43 |